Loading clinical trials...
Loading clinical trials...
Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin)
Conditions
Interventions
90Y Ibritumomab tiuxetan
Rituximab
Locations
7
France
Centre Hospitalier Universitaire de Lille
Lille, France
Centre Hospitalier Universitaire de Nantes
Nantes, France
Centre Henri Becquerel
Rouen, France
St George's Hospital
London, United Kingdom
The Christie NHS Foundation Trust
Manchester, United Kingdom
Poole Hospital NHS Foundation Trust
Poole, United Kingdom
Start Date
June 6, 2007
Primary Completion Date
January 1, 2011
Completion Date
November 6, 2015
Last Updated
October 15, 2019
NCT06337318
NCT05006716
NCT06026319
NCT07128641
NCT06510361
NCT01804686
Lead Sponsor
The Christie NHS Foundation Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions